Madryn Asset Management, LP bought VERO once, on Mar 26, 2026

Madryn Asset Management, LP is a New York-based alternative asset management firm founded in 2017, specializing in investments in innovative healthcare companies across biopharma, medtech, diagnostics, life sciences, and healthcare IT sectors.( The firm provides flexible, customized financing solutions to support growth and innovation, drawing on extensive experience in investment management and healthcare to generate strong risk-adjusted returns for its limited partners while incorporating ESG considerations as a signatory to the UN Principles for Responsible Investing.(

With offices at 330 Madison Avenue in New York and a portfolio value of approximately $36 million across five holdings, including significant positions in Standard BioTools Inc. (SLGC), Establishment Labs Holdings Inc. (ESTA), and Venus Concept Inc. (VERO), Madryn recently reported owning 91% of VERO as of January 15, 2026, per 13D/G filings.( Leadership includes Managing Partner Dr. Avinash Amin, Managing Director Alexander Marcantonio, Principal Addison Wright, and Vice President Austin Ferrone.( The firm manages closed funds such as Madryn Health Partners II and has been involved in funding rounds like the $2.5 million debt for Greenbrook TMS.(

Written by Perplexity from public sources.